logo
Select company
Select metric
100%Gross Margin
VS
Market
84
Sector
78
Industry
53
History
-
$ 4.41Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information

Ticker

ABUS

Company Name

ARBUTUS BIOPHARMA CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARBUTUS BIOPHARMA CORP - Gross Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABUS - Gross % Historical data
DateGross ProfitGross MarginRevenues
6/30/2025$ 15.42M100%$ 15.42M
3/31/2025$ 6.4M100%$ 6.4M
12/31/2024$ 6.17M100%$ 6.17M
9/30/2024$ 6.74M100%$ 6.74M
6/30/2024$ 10.06M100%$ 10.06M
3/31/2024$ 12.99M100%$ 12.99M
12/31/2023$ 18.14M100%$ 18.14M
9/30/2023$ 22.24M100%$ 22.24M
6/30/2023$ 23.54M100%$ 23.54M
3/31/2023$ 33.13M100%$ 33.13M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) Gross % stands at 100%.
  • Over the past 5 years, ARBUTUS BIOPHARMA CORP's average Gross % has been 100%.
  • The median Gross % for ARBUTUS BIOPHARMA CORP during this period was 100%
  • ARBUTUS BIOPHARMA CORP reached its highest Gross % over the past 5 years at 100%.
  • The lowest Gross % recorded by ARBUTUS BIOPHARMA CORP in the same timeframe 100%

ARBUTUS BIOPHARMA CORP's Gross % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Gross % Benchmarks
CompanyGross %
ZBIO : ZENAS BIOPHARMA INC 100%QURE : UNIQURE NV 82.61%NUVB : NUVATION BIO INC 27.54%VIR : VIR BIOTECHNOLOGY INC 96.08%BCYC : BICYCLE THERAPEUTICS PLC 100%IMNM : IMMUNOME INC 100%RLAY : RELAY THERAPEUTICS INC 100%CAPR : CAPRICOR THERAPEUTICS INC 100%ALMS : ALUMIS INC 100%TSHA : TAYSHA GENE THERAPIES INC 100%

Definition of Gross Margin

[Calculation] Gross margin, also called gross profit margin, represents the percentage of total revenue that the company retains after subtracting direct costs associated with producing the goods and services sold by the company [CoR]. Calculated by dividing gross profit [GP] by [Revenue].
GP / Revenues
(=) Gross %
Gross % for ARBUTUS BIOPHARMA CORP is calculated as follows: GP [ $ 6.15M ] / Revenues [ $ 6.15M ]
(=) Gross % [ 100% ]

ABUS - Gross Margin, Last 5 years

100%

Minimum

Sep 30, 2020

100%

Maximum

Sep 30, 2020

100%

Average

100%

Median

Gross % Benchmark Analysis

The chart above depicts the distribution of Gross % for companies in the Total Stock Market. The average Gross % of the companies is 53.09% with a standard deviation of 31.59%.
The following table provides additional summary stats:
Gross % in the Market:
filtered constituents3.81K
min-72.25%
max150.26%
average53.09%
median49.46%
std31.59%